• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓小脑共济失调3型细胞模型中的钾通道功能障碍与静息膜电位去极化

Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.

作者信息

Jeub Monika, Herbst Martin, Spauschus Alexander, Fleischer Henrik, Klockgether Thomas, Wuellner Ullrich, Evert Bernd O

机构信息

Department of Neurology, University of Bonn Medical Center, Sigmund Freud-Strasse 25, D-53105 Bonn, Germany.

出版信息

Exp Neurol. 2006 Sep;201(1):182-92. doi: 10.1016/j.expneurol.2006.03.029. Epub 2006 Jun 12.

DOI:10.1016/j.expneurol.2006.03.029
PMID:16765348
Abstract

Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant inherited neurodegenerative disease caused by the expansion of a polyglutamine repeat within the disease protein, ataxin-3. There is growing evidence that neuronal electrophysiological properties are altered in a variety of polyglutamine diseases such as Huntington's disease and SCA1 and that these alterations may contribute to disturbances of neuronal function prior to neurodegeneration. To elucidate possible electrophysiological changes in SCA3, we generated a stable PC12 cell model with inducible expression of normal and mutant human full-length ataxin-3 and analyzed the electrophysiological properties after induction of the recombinant ataxin-3 expression. Neuronally differentiated PC12 cells expressing the expanded form of ataxin-3 showed significantly decreased viabilities and developed ultrastructural changes resembling human SCA3. Prior to neuronal cell death, we found a significant reduction of the resting membrane potential and a hyperpolarizing shift of the activation curve of the delayed rectifier potassium current. These findings indicate that electrophysiological properties are altered in mutant ataxin-3 expressing neuronal cells and may contribute to neuronal dysfunction in SCA3.

摘要

3型脊髓小脑共济失调(SCA3)是一种常染色体显性遗传的神经退行性疾病,由疾病蛋白ataxin-3内的多聚谷氨酰胺重复序列扩增引起。越来越多的证据表明,在多种多聚谷氨酰胺疾病(如亨廷顿舞蹈症和SCA1)中,神经元的电生理特性发生了改变,并且这些改变可能在神经退行性变之前就导致了神经元功能紊乱。为了阐明SCA3可能存在的电生理变化,我们构建了一个稳定的PC12细胞模型,可诱导表达正常和突变的人全长ataxin-3,并在诱导重组ataxin-3表达后分析其电生理特性。表达ataxin-3扩增形式的神经元分化PC12细胞显示活力显著降低,并出现类似于人类SCA3的超微结构变化。在神经元细胞死亡之前,我们发现静息膜电位显著降低,延迟整流钾电流的激活曲线发生超极化偏移。这些发现表明,表达突变ataxin-3的神经元细胞的电生理特性发生了改变,可能导致SCA3中的神经元功能障碍。

相似文献

1
Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.脊髓小脑共济失调3型细胞模型中的钾通道功能障碍与静息膜电位去极化
Exp Neurol. 2006 Sep;201(1):182-92. doi: 10.1016/j.expneurol.2006.03.029. Epub 2006 Jun 12.
2
[Polyglutamine-expanded ataxin-3 is degraded by autophagy].[多聚谷氨酰胺扩展的ataxin-3通过自噬降解]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Feb;27(1):23-8. doi: 10.3760/cma.j.issn.1003-9406.2010.01.005.
3
A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.在马查多-约瑟夫病样转基因小鼠的大脑中,一种突变的ataxin-3片段是由在氨基酸190 N端的一个位点进行加工产生的。
Neurobiol Dis. 2007 Sep;27(3):362-9. doi: 10.1016/j.nbd.2007.06.005. Epub 2007 Jun 13.
4
CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration.CDK5 保护 Ataxin-3 免受半胱天冬酶诱导的切割和神经退行性变。
J Neurochem. 2014 Jun;129(6):1013-23. doi: 10.1111/jnc.12684. Epub 2014 Mar 24.
5
Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.共济失调-3 蛋白修饰作为脊髓小脑共济失调 3 型的治疗策略:去除含有 CAG 的外显子。
Neurobiol Dis. 2013 Oct;58:49-56. doi: 10.1016/j.nbd.2013.04.019. Epub 2013 May 6.
6
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).钙蛋白酶介导的小脑共济失调 3 型(SCA3)发病机制中的 ataxin-3 裂解。
Hum Mol Genet. 2013 Feb 1;22(3):508-18. doi: 10.1093/hmg/dds449. Epub 2012 Oct 24.
7
Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.多聚谷氨酰胺扩增的ataxin-3通过抑制组蛋白乙酰转移酶(HAT)和损害组蛋白乙酰化,损害SCA3转基因小鼠浦肯野神经元的长时程抑制。
Brain Res. 2014 Oct 2;1583:220-9. doi: 10.1016/j.brainres.2014.08.019. Epub 2014 Aug 17.
8
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.一个新的人源化 ataxin-3 敲入小鼠模型结合了 SCA3/MJD 的遗传特征、神经元和神经胶质的发病机制以及疾病的晚期发病。
Neurobiol Dis. 2015 Jan;73:174-88. doi: 10.1016/j.nbd.2014.09.020. Epub 2014 Oct 7.
9
Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease.马查多-约瑟夫病细胞模型中抗氧化酶活性降低及线粒体DNA损伤增加。
J Neurosci Res. 2009 Jun;87(8):1884-91. doi: 10.1002/jnr.22011.
10
Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.蛋白酶体参与多聚谷氨酰胺疾病的证据:在SCA3/MJD中定位于核内包涵体并在体外抑制多聚谷氨酰胺聚集。
Hum Mol Genet. 1999 Apr;8(4):673-82. doi: 10.1093/hmg/8.4.673.

引用本文的文献

1
Mitochondrial Dysfunction and Decreased Cytochrome in Cell and Animal Models of Machado-Joseph Disease.Machado-Joseph 病的细胞和动物模型中线粒体功能障碍和细胞色素减少。
Cells. 2023 Oct 3;12(19):2397. doi: 10.3390/cells12192397.
2
Fluorescence Imaging of Cell Membrane Potential: From Relative Changes to Absolute Values.细胞膜电位的荧光成像:从相对变化到绝对值。
Int J Mol Sci. 2023 Jan 26;24(3):2435. doi: 10.3390/ijms24032435.
3
ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.
脊髓性肌萎缩症和延髓性肌肉萎缩症的细胞模型中氯离子通道电流的改变:一种多聚谷氨酰胺疾病。
J Mol Neurosci. 2021 Mar;71(3):662-674. doi: 10.1007/s12031-020-01687-5. Epub 2020 Aug 28.
4
Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.通过整合病理生物标志物和治疗策略确定3型脊髓小脑共济失调/马查多-约瑟夫病的治疗靶点
Int J Mol Sci. 2020 Apr 26;21(9):3063. doi: 10.3390/ijms21093063.
5
Pathogenic mechanisms underlying spinocerebellar ataxia type 1.脊髓小脑共济失调 1 型的发病机制。
Cell Mol Life Sci. 2020 Oct;77(20):4015-4029. doi: 10.1007/s00018-020-03520-z. Epub 2020 Apr 18.
6
Over-expressed human TREK-1 inhibits CHO cell proliferation via inhibiting PKA and p38 MAPK pathways and subsequently inducing G1 arrest.过表达的人TREK-1通过抑制PKA和p38 MAPK信号通路,进而诱导G1期阻滞来抑制CHO细胞增殖。
Acta Pharmacol Sin. 2016 Sep;37(9):1190-8. doi: 10.1038/aps.2016.65. Epub 2016 Jul 11.
7
Toward understanding Machado-Joseph disease.理解马查多-约瑟夫病。
Prog Neurobiol. 2012 May;97(2):239-57. doi: 10.1016/j.pneurobio.2011.11.006. Epub 2011 Nov 23.
8
Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3.早发性小脑生理学改变伴随多聚谷氨酰胺疾病脊髓小脑共济失调 3 型的运动功能障碍。
J Neurosci. 2011 Sep 7;31(36):13002-14. doi: 10.1523/JNEUROSCI.2789-11.2011.
9
Physiologic alterations in ataxia: channeling changes into novel therapies.共济失调的生理改变:将变化引入新疗法。
Arch Neurol. 2009 Oct;66(10):1196-201. doi: 10.1001/archneurol.2009.212.